deltatrials

Parkinson's disease Trials in Rochester, United States

Conditions / Parkinson's disease / Rochester, United States

Research into Parkinson's disease spans multiple therapeutic approaches and trial phases.

48 total trials for this combination

Showing top 10 of 48 trials

Trials

NCT ID Title Status Phase
NCT04477785 PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort RECRUITING
NCT00040404 Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease TERMINATED PHASE2/PHASE3
NCT06680830 A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease RECRUITING
NCT00086073 Parkinson's Research: The Organized Genetics Initiative COMPLETED
NCT00086190 Study of Antidepressants in Parkinson's Disease COMPLETED PHASE3
NCT03924414 Trial of Parkinson's And Zoledronic Acid ACTIVE_NOT_RECRUITING PHASE4
NCT00036205 Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease TERMINATED PHASE3
NCT02168842 Efficacy of Isradipine in Early Parkinson Disease COMPLETED PHASE3
NCT00740714 Effects of Coenzyme Q10 (CoQ) in Parkinson Disease TERMINATED PHASE3
NCT00363727 Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's COMPLETED PHASE3

Related Pages